scholarly article | Q13442814 |
P356 | DOI | 10.1152/AJPGI.00043.2010 |
P698 | PubMed publication ID | 20378829 |
P50 | author | Alan R. Zinsmeister | Q64368056 |
Michael Camilleri | Q64750736 | ||
Archana Rao | Q88457445 | ||
Duane Burton | Q89104732 | ||
Noriaki Manabe | Q91057547 | ||
Ken Haruma | Q94925672 | ||
Banny S Wong | Q116781676 | ||
Irene A Busciglio | Q116781681 | ||
P2860 | cites work | Stool form scale as a useful guide to intestinal transit time | Q28249217 |
Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey | Q29547851 | ||
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder | Q31837263 | ||
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions | Q33780740 | ||
Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome | Q33977333 | ||
Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation | Q35199943 | ||
Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects | Q37100282 | ||
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome | Q39375148 | ||
Towards a less costly but accurate test of gastric emptying and small bowel transit | Q41152382 | ||
Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans | Q43340470 | ||
Effect of Dai-kenchu-to on gastrointestinal motility based on differences in the site and timing of administration | Q43346117 | ||
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome | Q43352181 | ||
Mechanisms for contractile effect of Dai-kenchu-to in isolated guinea pig ileum | Q43561381 | ||
Effects of Dai-kenchu-to, a herbal medicine, on uterine and intestinal motility | Q43640606 | ||
Intraduodenal and intrajejunal administration of the herbal medicine, dai-kenchu-tou, stimulates small intestinal motility via cholinergic receptors in conscious dogs | Q43645933 | ||
Mechanism of atropine-resistant contraction induced by Dai-kenchu-to in guinea pig ileum | Q43656553 | ||
Dai-kenchu-to enhances accelerated small intestinal movement | Q43772074 | ||
Abatement of morphine-induced slowing in gastrointestinal transit by Dai-kenchu-to, a traditional Japanese herbal medicine | Q43944068 | ||
Effect of Dai-kenchu-to (Da-Jian-Zhong-Tang) on the delayed intestinal propulsion induced by chlorpromazine in mice | Q44397714 | ||
Human gastric emptying and colonic filling of solids characterized by a new method | Q44578488 | ||
Effect of Dai-kenchu-to on levels of 3 brain-gut peptides (motilin, gastrin and somatostatin) in human plasma | Q47697006 | ||
The pharmacological effects of Daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus | Q47765980 | ||
Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition. | Q51182368 | ||
Effect of Dai-kenchu-to on gastrointestinal motility and gastric emptying. | Q51426882 | ||
P433 | issue | 6 | |
P304 | page(s) | G970-5 | |
P577 | publication date | 2010-04-08 | |
P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
P1476 | title | Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans | |
P478 | volume | 298 |
Q37275236 | A valid approach in refractory glossodynia: a single-institution 5-year experience treating with Japanese traditional herbal (kampo) medicine |
Q47723061 | Acceleration of small bowel motility after oral administration of dai-kenchu-to (TJ-100) assessed by cine magnetic resonance imaging |
Q42112352 | Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion |
Q35798344 | Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902). |
Q53432185 | Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study). |
Q26795516 | Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchuto |
Q35313317 | Constipation and herbal medicine |
Q47100364 | Daikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APCmin/+ Mouse Models of Experimental Colon Cancer. |
Q42285679 | Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal |
Q33978418 | Daikenchuto (TU-100) ameliorates colon microvascular dysfunction via endogenous adrenomedullin in Crohn's disease rat model |
Q36648890 | Daikenchuto (TU-100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K. |
Q33722390 | Daikenchuto, a traditional Japanese herbal medicine, ameliorates postoperative ileus by anti-inflammatory action through nicotinic acetylcholine receptors |
Q33898423 | Daikenchuto, a traditional Japanese herbal medicine, for the maintenance of surgically induced remission in patients with Crohn's disease: a retrospective analysis of 258 patients |
Q92368552 | Daikenchuto, a traditional Japanese herbal medicine, promotes colonic transit by inducing a propulsive movement pattern |
Q37640792 | Depolarizing Effects of Daikenchuto on Interstitial Cells of Cajal from Mouse Small Intestine |
Q36821598 | Effect of Daikenchuto (TJ-100) on abdominal bloating in hepatectomized patients |
Q47665478 | Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001). |
Q37477492 | Effect of Traditional Japanese Medicine, Daikenchuto (TJ-100) in Patients With Chronic Constipation |
Q36743023 | Effects of Daikenchuto on Abdominal Bloating Accompanied by Chronic Constipation: A Prospective, Single-Center Randomized Open Trial |
Q43327978 | Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial |
Q35012028 | Effects of traditional Chinese herbal medicine San-Huang-Xie-Xin-Tang on gastrointestinal motility in mice |
Q52564495 | Efficacy and Safety of Daikenchuto for Constipation and Dose-Dependent Differences in Clinical Effects. |
Q37345334 | Efficacy of Japanese traditional (Kampo) medicine for treating chemotherapy-induced peripheral neuropathy: A retrospective case series study |
Q33586854 | Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation |
Q49165336 | Enhanced anastomotic healing by Daikenchuto (TJ-100) in rats |
Q34527652 | Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine |
Q35274160 | Hydroxy-α sanshool induces colonic motor activity in rat proximal colon: a possible involvement of KCNK9 |
Q36201537 | Intestinal, portal, and peripheral profiles of daikenchuto (TU-100)'s active ingredients after oral administration |
Q26830898 | Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application |
Q42695148 | New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond |
Q42025254 | Novel method for studying postoperative ileus in mice. |
Q39850032 | Profiling of the Compounds Absorbed in Human Plasma and Urine after Oral Administration of a Traditional Japanese (Kampo) Medicine, Daikenchuto |
Q34856264 | Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells |
Q28085763 | Status of urological Kampo medicine: a narrative review and future vision |
Q33654829 | TU-100 (Daikenchuto) and ginger ameliorate anti-CD3 antibody induced T cell-mediated murine enteritis: microbe-independent effects involving Akt and NF-κB suppression |
Q52776219 | TU-100 exerts a protective effect against bacterial translocation by maintaining the tight junction. |
Q54399199 | The effect of Daikenchuto on postoperative intestinal motility in patients with right-side colon cancer. |
Q55155964 | The effects of the herbal medicine Daikenchuto (TJ-100) after esophageal cancer resection, open-label, randomized controlled trial. |
Q37865426 | The opioid component of delayed gastrointestinal recovery after bowel resection |
Q33893803 | Traditional Japanese medicine daikenchuto improves functional constipation in poststroke patients |
Q38765361 | Transient receptor potential ankyrin 1 agonists improve intestinal transit in a murine model of postoperative ileus |
Q58573108 | Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD |
Search more.